ArticleiScience2025

EPYC promotes laryngeal cancer carcinogenesis and angiogenesis by docking to VEGFR1: A novel therapeutic target.

Dongmei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.